Katina Dorton - 17 Oct 2025 Form 3 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Director
Signature
/s/ Bryant D. Lim, Attorney-in-Fact
Issuer symbol
PRLD
Transactions as of
17 Oct 2025
Net transactions value
$0
Form type
3
Filing time
20 Oct 2025, 16:01:15 UTC
Previous filing
18 Aug 2025
Next filing
05 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dorton Katina Director C/O PRELUDE THERAPEUTICS INCORPORATED, 175 INNOVATION BOULEVARD, WILMINGTON /s/ Bryant D. Lim, Attorney-in-Fact 20 Oct 2025 0001617541

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney